A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

CRISPR-Cas9 is effective at generating small mutations ... and colleagues used Easi-CRISPR to reprogram the structure and function of human T cells without the need for viral vectors 6.

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Doudna said she does not support using CRISPR/Cas9 to make gene-edited babies. Base editors fuse enzymes that can alter the chemical structure of DNA bases to a “dead” version of CRISPR/Cas9 ...

To manipulate the gut microbiome of a mouse at the species level, Turnbaugh and his team chose the CRISPR-Cas9 system, a type II CRISPR system ... process in which a bacterium produces a needle-like ...

Researchers at the Broad Institute of MIT and Harvard and Cyrus Biotechnology have now engineered two CRISPR nucleases, Cas9 and Cas12 ... David Baker that develops structure-based computational ...

Potent in vivo gene editing in skeletal muscle of non-human primates by a novel, ultracompact CRISPR system delivered via a single AAV vector.

It's clear though that these companies need time. Even with the only approved CAS9 based treatment out there, CRISPR is still years away from achieving its potential. In a recent update to ...

CRISPR uses an enzyme known as Cas9 to cut and alter DNA ... ultrasound-enabled CRISPR to target the telomere, a DNA-protein structure found at the end of chromosomes that protects the ...

CRISPR stocks are high risk but hold potential for aggressive investors. CRISPR Therapeutics and its partner Vertex Pharmaceuticals have the only approved CRISPR therapy. Several other biotech ...